| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,197 | 47,306 | 48,819 | 49,692 | | Cost of Revenue | 21,552 | 20,940 | 21,570 | 24,216 | | | Gross Profit | 26,645 | 26,366 | 27,249 | 25,476 | | | Operating Expenses | | Research Development | 9,940 | 9,582 | 9,338 | 8,648 | | Selling General and Administrative | 17,400 | 17,215 | 18,392 | 15,870 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (695) | (431) | (481) | 958 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30 | 39 | 72 | 113 | | Earnings Before Interest And Taxes | (665) | (392) | (409) | 1,071 | | Interest Expense | 29 | 38 | 44 | 106 | | Income Before Tax | (694) | (430) | (453) | 965 | | Income Tax Expense | (225) | (100) | (40) | 350 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (469) | (330) | (413) | 615 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (469) | (330) | (413) | 615 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($469) | ($330) | ($413) | $615 |
|
0.07% Nasdaq 
0.64%
Income Statement
